Table 1 Basic demographic and clinic characteristics of the study population

Age

57.37 ± 8.41

56.98 ± 10.98

0.985

BSA

1.69 ± 0.17

1.70 ± 0.21

0.715

Sex (female), n (%)

26 (48.1)

79 (53.4)

0.472

Smoking, n (%)

–

69 (46.6)

–

Drinking, n (%)

–

28 (18.9)

–

Hypertension,n (%)

–

91 (61.5)

–

Hyperlipidemia, n (%)

–

29 (19.6)

–

Laboratory Examinations

  FBG

–

6.81 (5.52,8.31)

–

  HDL-C

–

1.09 (0.89, 1.36)

–

  LDL-C

–

2.33 (1.72, 2.92)

–

  TG

–

1.51 (1.09, 2.17)

–

  TC

–

4.16 (3.45, 4.94)

–

Medication

–

  Beta-blockers

–

35 (23.6)

–

  Calcium-channel blocker, n (%)

–

16 (10.8)

–

  ACEI/ARB, n (%)

–

52 (35.1)

–

  Diuretics, n (%)

–

26 (17.6)

–

Anti-diabetic treatment

  Insulin, n (%)

–

27 (18.2)

–

  Metformin, n (%)

–

21 (14.2)

–

  Sulfonylurea, n (%)

–

40 (27.0)

–

  α-Glucosidase inhibitor, n (%)

–

42 (28.4)

–

  Other, n (%)

–

6 (4.1)

–

  Non-drug, n (%)

–

24 (16.2)

–